Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
Erasmus MC · Istanbul University · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,163
total citations
- FWCI
- 67.44
- Percentile
- 100%
- References
- 34
Citations per year
Authors
14Topics & keywords
Topics
Keywords
- Medicine
- Lamivudine
- Internal medicine
- Pegylated interferon
- HBeAg
- Gastroenterology
- Combination therapy
- Placebo
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.